cdmo.directory
← Home
Excellos Labs logo

Excellos Labs

Cell therapy CDMO from donor to dose, under cGMP in ISO 7 cleanrooms

Cell therapy CDMO in San Diego offering apheresis donor collection, cell isolation, transduction, expansion, fill/finish and cryopreservation under cGMP in ISO 7 cleanrooms. Supports TIL, CAR-T/NK and TCR programs from starting material through commercial-scale GMP manufacturing. Headquartered in San Diego, United States.

Modalities

Services

About this organization

Overview

Excellos Labs is a cell therapy CDMO founded in 2021 as an independent spinout of the San Diego Blood Bank. The company is based in downtown San Diego and is now a subsidiary of OrganaBio, a vertically integrated CTDMO.

Services

  • Customized apheresis donor cell collections
  • Cell isolation and enrichment, including PBMC and leukopak processing and T/NK cell isolation
  • Process development and cGMP manufacturing, including transduction, expansion, harvest and cryopreservation
  • Fill/finish and third-party cryopreservation
  • Quality assurance and phase-appropriate regulatory support

Capabilities

Production runs in five ISO 7 cleanroom suites under cGMP. The company describes support for adoptive cell therapies including TIL therapy, autologous and allogeneic CAR-T/NK therapies, and TCR therapy.

Donor sourcing draws from a consented, recallable donor pool with diversity in ethnicity, sex and age. Donor screening includes an immune profile covering metabolic and effector potential of cells.

Network

As a subsidiary of OrganaBio, Excellos Labs operates within a coast-to-coast CTDMO with cGMP capabilities in Miami and San Diego under one quality management system.

Locations

  • San Diego

    San Diego · CA · US

  • Miami

    Miami · FL · US

Related companies

Similar profiles by shared services, modalities, and capabilities.

Submit a verified review for this organization.

Markdown mirror: /companies/excelloslabs.md